Join Our Penny Stock Newsletter

Northwest Biotherapeutics, Inc. - NWBO

RSI %R Tweets Wolf Odds
51 -48 18 9.76%

Industry: Biotechnology / Sector: Healthcare

NWBO Chart

NWBO Quote

Prev Close: 0.3211
Open: 0.3251
Last Trade: 0.325765
Change %: +1.450%
Change: +0.0046650
Volume: 534645
Avg Vol: 1978722
Relative Vol: 0.27
Day Range: 0.32 -0.3259
52-Week Range: 0.1400 - 0.9800
Market Cap: 50.28M
Float: 249.83M
Shares Outstanding: 315.12M
Insider Owned: 5.81%
Institution Owned: 18.92%
Beta: 2.61
PE Ratio: 0.00
EPS: -0.3940

NWBO Detailed Stats

RSI:51.44 %K:52.05 Wolf Odds: 9.76% Tweets Today:18 SMA14:0.3283
stochRSI:0.53 %D:51.76 Wolf Trend:0.47 Tweet Avg:24 Pivot Price:0.3238883
%R:-47.95 %B:0.42 Wolf 3-Day:0.45 Avg. Change 3-Day:+0.840% Resistance 1:0.3277767
MFI:55.82 Bandwidth:0.090473 Wolf 7-Day:0.42 Avg. Change 7-Day:-0.379% Resistance 2:0.3297883
WolfPeak:0.51 Vortex Indicator:0.06 Wolf 14-Day:0.53 Avg. Change 14-Day:+0.35% Support 1:0.3218767
ROC 7/14:-2.7567/3.4175 Aroon Oscillator:28.5714 EOM:-0.001154 Relative Vol:0.27 Support 2:0.3179883
RSI Alert:None WolfPeak Alert:None Vortex Alert:None Aroon Alert:None EOM Alert:None

Featured News *

NWBO News

    NWBO Description

    Northwest Biotherapeutics, Inc., a biotechnology company, discovers and develops personalized immune therapies for cancer in the United States and internationally. The company develops its products based on DCVax, a platform technology that uses activated dendritic cells to mobilize a patient?s own immune system to attack cancer. It is developing DCVax-L, a product in Phase III clinical trials to treat Glioblastome multiforme, a brain cancer; and DCVax-Direct, a product in Phase I/II clinical trials to treat various types of inoperable solid tumor cancers. The company was founded in 1996 and is headquartered in Bethesda, Maryland.
    Website: http://www.nwbio.com

    NWBO Comments

    Recent NWBO Tweets

    Powered by Ekonomys ver. 9

    StockWolf is dedicated to Penny Stock quotes and data to provide information, news, and education on penny stocks to help in your due diligence.

    30min+ delay on data. All data is picked with automated algorithms and not vetted for accuracy. Please, read ALL information and disclaimers before using our service. StockWolf is not a licensed financial adviser, and not liable for your loses. Trade responsibly. This site is for education purposes only not a recommendation to buy/sell

    Information

    Stock Wolf Twitter

    Stock Wolf Facebook